Cardiac Marker Testing Market Growth, Size, Share, Trends, and Forecast 2032

Cardiac Marker Testing Market

Cardiac Marker Testing Market Analysis By Type (Troponin I and T, Brain Natriuretic peptide (Bnp or Nt-Probnp), Creatine kinase-MB (CK-MB), Myoglobin, HIGH-sensitivity C-reactive protein (hs-CRP), and Other Biomarkers), By Product (Instruments, Chemiluminescence, Immunofluorescence, ELISA, Immunochromatography, Reagents and Kits), By Disease (Acute Coronary Syndrome, Atherosclerosis, Congestive Heart Failure, Myocardial Infarction, and Ischemia), By Type of Testing (Academic Institutions, Laboratory Testing, and Point-Of-Care Testing), and By Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2024-2032

Category: Medical Device Report Format : PDF Pages: 214 Report Code: ZMR-870 Published Date: Jul-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 4.30 Billion USD 9.29 Billion 9.05% 2023

 

Table Of Content

  • Chapter 1.Preface
    • 1.1.ReportDescription
    • 1.2.Report Scope
  • Chapter 2.Research Methodology
    • 2.1.Research Methodology
    • 2.2.Secondary Research
    • 2.3.Primary Research
    • 2.4.Models
      • 2.4.1.Company Share Analysis Model
      • 2.4.2.Revenue Based Modeling
    • 2.5.Research Limitations
  • Chapter 3.Executive Summary
    • 3.1.Global Cardiac Marker TestingMarket, 2016–2026 (USD Million)
    • 3.2.Global Cardiac Marker TestingMarket: Snapshot
  • Chapter 4.Cardiac Marker TestingMarket – Industry Analysis
    • 4.1.Introduction
    • 4.2.Market Drivers
      • 4.2.1.Driving Factor 1 Analysis
      • 4.2.2.Driving Factor 2 Analysis:
    • 4.3.Market Restraints
      • 4.3.1.Restraining Factor Analysis
    • 4.4.Market Opportunities
      • 4.4.1.Market Opportunity & Use-case Anaysis
      • 4.4.2.Use – Cases for Cardiac Marker Testing
    • 4.5.Porter’s Five Forces Analysis
    • 4.6.COVID 19 Impact Analysis
      • 4.6.1.1.Impact on Product Development and Technology Adoption
      • 4.6.1.2.Gap Analysis
  • Chapter 5.Investment Proposition Analysis
    • 5.1.Global Cardiac Marker Testing Market Attractiveness, By Diseases
    • 5.2.Global Cardiac Marker Testing Market Attractiveness, By Testing
    • 5.3.Global Cardiac Marker Testing Market Attractiveness, By Product Type
    • 5.4.Global Cardiac Marker Testing Market Attractiveness, By Type
    • 5.5.Global Cardiac Marker Testing Market Attractiveness, By Region
  • Chapter 6.Competitive Landscape
    • 6.1.Company Market Share Analysis - 2019
      • 6.1.1.Global Cardiac Marker Testing Market: Company Market Share, 2019
    • 6.2.Strategic Developments
    • 7.1.Global Cardiac Marker Testing Market Overview: by Diseases
      • 7.1.1.Global Cardiac Marker Testing Market Revenue Share, by Diseases, 2019 & 2026
    • 7.2.Global Cardiac Marker Testing Market Analysis/Overview – By Diseases
      • 7.2.1.Congestive heart failure – Overview/Analysis
      • 7.2.2.Myocardial infarction – Overview/Analysis
    • 7.3.Congestive heart failure
      • 7.3.1.Global Cardiac Marker Testing Market for Congestive heart failure, Revenue (USD Million) 2016 - 2026
    • 7.4.Myocardial infarction
      • 7.4.1.Global Cardiac Marker Testing Market for Myocardial infarction, Revenue (USD Million) 2016 - 2026
    • 8.1.Global Cardiac Marker Testing Market Overview: by Testing
      • 8.1.1.Global Cardiac Marker Testing Market Revenue Share, by Testing, 2019 & 2026
    • 8.2.Global Cardiac Marker Testing Market Analysis/Overview – By Testing
      • 8.2.1.Point-of-care testing – Overview/Analysis
      • 8.2.2.Laboratory testing – Overview/Analysis
    • 8.3.Point-of-care testing
      • 8.3.1.Global Cardiac Marker Testing Market for Point-of-care testing, Revenue (USD Million) 2016 - 2026
    • 8.4.Laboratory testing
      • 8.4.1.Global Cardiac Marker Testing Market for Laboratory testing, Revenue (USD Million) 2016 - 2026
    • 9.1.Global Cardiac Marker Testing Market Overview: by Product Type
      • 9.1.1.Global Cardiac Marker Testing Market Revenue Share, by Product Type, 2019 & 2026
    • 9.2.Global Cardiac Marker Testing Market Analysis/Overview – By Product Type
      • 9.2.1.Immunofluorescence – Overview/Analysis
      • 9.2.2.Immunochromatography – Overview/Analysis
      • 9.2.3.Instrument – Overview/Analysis
      • 9.2.4.Reagents and kits – Overview/Analysis
      • 9.2.5.Chemiluminescence – Overview/Analysis
      • 9.2.6.Enzyme-linked immunosorbent assay – Overview/Analysis
    • 9.3.Immunofluorescence
      • 9.3.1.Global Cardiac Marker Testing Market for Immunofluorescence, Revenue (USD Million) 2016 - 2026
    • 9.4.Immunochromatography
      • 9.4.1.Global Cardiac Marker Testing Market for Immunochromatography, Revenue (USD Million) 2016 - 2026
    • 9.5.Instrument
      • 9.5.1.Global Cardiac Marker Testing Market for Instrument, Revenue (USD Million) 2016 - 2026
    • 9.6.Reagents and kits
      • 9.6.1.Global Cardiac Marker Testing Market for Reagents and kits, Revenue (USD Million) 2016 - 2026
    • 9.7.Chemiluminescence
      • 9.7.1.Global Cardiac Marker Testing Market for Chemiluminescence, Revenue (USD Million) 2016 - 2026
    • 9.8.Enzyme-linked immunosorbent assay
      • 9.8.1.Global Cardiac Marker Testing Market for Enzyme-linked immunosorbent assay, Revenue (USD Million) 2016 - 2026
    • 10.1.Global Cardiac Marker Testing Market Overview: by Type
      • 10.1.1.Global Cardiac Marker Testing Market Revenue Share, by Type, 2019 & 2026
    • 10.2.Global Cardiac Marker Testing Market Analysis/Overview – By Type
      • 10.2.1.C-reactive protein – Overview/Analysis
      • 10.2.2.Troponin I and T – Overview/Analysis
      • 10.2.3.Brain natriuretic peptide or NT-proBNP – Overview/Analysis
      • 10.2.4.CK-MB – Overview/Analysis
      • 10.2.5.Others – Overview/Analysis
    • 10.3.C-reactive protein
      • 10.3.1.Global Cardiac Marker Testing Market for C-reactive protein, Revenue (USD Million) 2016 - 2026
    • 10.4.Troponin I and T
      • 10.4.1.Global Cardiac Marker Testing Market for Troponin I and T, Revenue (USD Million) 2016 - 2026
    • 10.5.Brain natriuretic peptide or NT-proBNP
      • 10.5.1.Global Cardiac Marker Testing Market for Brain natriuretic peptide or NT-proBNP, Revenue (USD Million) 2016 - 2026
    • 10.6.CK-MB
      • 10.6.1.Global Cardiac Marker Testing Market for CK-MB, Revenue (USD Million) 2016 - 2026
    • 10.7.Others
      • 10.7.1.Global Cardiac Marker Testing Market for Others, Revenue (USD Million) 2016 - 2026
  • Chapter 11.Cardiac Marker TestingMarket– Regional Analysis
    • 11.1.Global Cardiac Marker TestingMarket: Regional Overview
      • 11.1.1.Global Cardiac Marker Testing Market Revenue Share, by Region, 2019 & 2026
      • 11.1.2.GlobalCardiac Marker Testing Market Revenue, by Region, 2016 – 2026 (USD Million)
    • 11.2.North America
      • 11.2.1.North AmericaCardiac Marker Testing Market Revenue, 2016 - 2026 (USD Million)
      • 11.2.2.North AmericaCardiac Marker Testing Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 11.2.3.North AmericaCardiac Marker Testing Market Revenue, by Diseases, 2016 – 2026
      • 11.2.4.North AmericaCardiac Marker Testing Market Revenue, by Testing, 2016 – 2026
      • 11.2.5.North AmericaCardiac Marker Testing Market Revenue, by Product Type, 2016 – 2026
      • 11.2.6.North AmericaCardiac Marker Testing Market Revenue, by Type, 2016 – 2026
      • 11.2.7. U.S.
      • 11.2.8.Canada
    • 11.3.Europe
      • 11.3.1.EuropeCardiac Marker Testing Market Revenue, 2016 - 2026 (USD Million)
      • 11.3.2.EuropeCardiac Marker Testing Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 11.3.3.EuropeCardiac Marker Testing Market Revenue, by Diseases, 2016 – 2026
      • 11.3.4.EuropeCardiac Marker Testing Market Revenue, by Testing, 2016 – 2026
      • 11.3.5.EuropeCardiac Marker Testing Market Revenue, by Product Type, 2016 – 2026
      • 11.3.6.EuropeCardiac Marker Testing Market Revenue, by Type, 2016 – 2026
      • 11.3.7.Germany
      • 11.3.8.France
      • 11.3.9. U.K.
      • 11.3.10.Italy
      • 11.3.11.Spain
      • 11.3.12.Rest of Europe
    • 11.4.Asia Pacific
      • 11.4.1.Asia PacificCardiac Marker Testing Market Revenue, 2016 - 2026 (USD Million)
      • 11.4.2.Asia PacificCardiac Marker Testing Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 11.4.3.Asia PacificCardiac Marker Testing Market Revenue, by Diseases, 2016 – 2026
      • 11.4.4.Asia PacificCardiac Marker Testing Market Revenue, by Testing, 2016 – 2026
      • 11.4.5.Asia PacificCardiac Marker Testing Market Revenue, by Product Type, 2016 – 2026
      • 11.4.6.Asia PacificCardiac Marker Testing Market Revenue, by Type, 2016 – 2026
      • 11.4.7.China
      • 11.4.8.Japan
      • 11.4.9.India
      • 11.4.10.South Korea
      • 11.4.11.South-East Asia
      • 11.4.12.Rest of Asia Pacific
    • 11.5.Latin America
      • 11.5.1.Latin AmericaCardiac Marker Testing Market Revenue, 2016 - 2026 (USD Million)
      • 11.5.2.Latin AmericaCardiac Marker Testing Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 11.5.3.Latin AmericaCardiac Marker Testing Market Revenue, by Diseases, 2016 – 2026
      • 11.5.4.Latin AmericaCardiac Marker Testing Market Revenue, by Testing, 2016 – 2026
      • 11.5.5.Latin AmericaCardiac Marker Testing Market Revenue, by Product Type, 2016 – 2026
      • 11.5.6.Latin AmericaCardiac Marker Testing Market Revenue, by Type, 2016 – 2026
      • 11.5.7.Brazil
      • 11.5.8.Mexico
      • 11.5.9.Rest of Latin America
    • 11.6.The Middle-East and Africa
      • 11.6.1.The Middle-East and AfricaCardiac Marker Testing Market Revenue, 2016 - 2026 (USD Million)
      • 11.6.2.The Middle-East and AfricaCardiac Marker Testing Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 11.6.3.The Middle-East and AfricaCardiac Marker Testing Market Revenue, by Diseases, 2016 – 2026
      • 11.6.4.The Middle-East and AfricaCardiac Marker Testing Market Revenue, by Testing, 2016 – 2026
      • 11.6.5.The Middle-East and AfricaCardiac Marker Testing Market Revenue, by Product Type, 2016 – 2026
      • 11.6.6.The Middle-East and AfricaCardiac Marker Testing Market Revenue, by Type, 2016 – 2026
      • 11.6.7.GCC Countries
      • 11.6.8.South Africa
      • 11.6.9.Rest of Middle-East Africa
  • Chapter 12.Company Profiles
    • 12.1.Siemens AG
      • 12.1.1.Company Overview
      • 12.1.2.Financial Overview
      • 12.1.3.Product Portfolio
      • 12.1.4.Business Strategy
      • 12.1.5.Recent Developments
    • 12.2.Abbott Laboratories
    • 12.3.Danaher Corporation
    • 12.4.bioMérieux SA
    • 12.5.Alere, Inc.
    • 12.6.Roche Diagnostics Ltd.
    • 12.7.Ortho Clinical Diagnostics
    • 12.8.LSI Medience Corporation
    • 12.9.Randox laboratories Ltd
    • 12.1.Guangzhou Wondfo Biotech Co., Ltd.
    • 12.11.Bio-Rad Laboratories, Inc.
    • 12.12.Helomics Corporation
    • 12.13.Becton
    • 12.14.Dickinson and Company
    • 12.15.Avantra Biosciences
    • 12.16.Enzo Biochem
    • 12.17.Others

Table Of Figures

List of Figures 

FIG. 1 Research Methodology
FIG. 2 Research Methodology – Basic Overview
FIG. 3 Research Methodology – Detailed View
FIG. 4 Global Cardiac Marker TestingMarketRevenue, 2016 - 2026 (USD Million)
FIG. 5 Porter’s Five Forces Analysis for Global Cardiac Marker Testing Market
FIG. 6 Global Cardiac Marker Testing Market Attractiveness, By Diseases
FIG. 7 Global Cardiac Marker Testing Market Attractiveness, By Testing
FIG. 8 Global Cardiac Marker Testing Market Attractiveness, By Product Type
FIG. 9 Global Cardiac Marker Testing Market Attractiveness, By Type
FIG. 10 Global Cardiac Marker Testing Market Attractiveness, By End-User
FIG. 11 Company Share Analysis, 2019
FIG. 12 Global Cardiac Marker Testing Market Revenue Share, by Diseases, 2019 & 2026
FIG. 13 Global Cardiac Marker Testing Market for Congestive heart failure, Revenue (USD Million) 2016 - 2026
FIG. 14 Global Cardiac Marker Testing Market for Myocardial infarction, Revenue (USD Million) 2016 - 2026
FIG. 15 Global Cardiac Marker Testing Market Revenue Share, by Testing, 2019 & 2026
FIG. 16 Global Cardiac Marker Testing Market for Point-of-care testing, Revenue (USD Million) 2016 - 2026
FIG. 17 Global Cardiac Marker Testing Market for Laboratory testing, Revenue (USD Million) 2016 - 2026
FIG. 18 Global Cardiac Marker Testing Market Revenue Share, by Product Type, 2019 & 2026
FIG. 19 Global Cardiac Marker Testing Market for Immunofluorescence, Revenue (USD Million) 2016 - 2026
FIG. 20 Global Cardiac Marker Testing Market for Immunochromatography, Revenue (USD Million) 2016 - 2026
FIG. 21 Global Cardiac Marker Testing Market for Instrument, Revenue (USD Million) 2016 - 2026
FIG. 22 Global Cardiac Marker Testing Market for Reagents and kits, Revenue (USD Million) 2016 - 2026
FIG. 23 Global Cardiac Marker Testing Market for Chemiluminescence, Revenue (USD Million) 2016 - 2026
FIG. 24 Global Cardiac Marker Testing Market for Enzyme-linked immunosorbent assay, Revenue (USD Million) 2016 - 2026
FIG. 25 Global Cardiac Marker Testing Market Revenue Share, by Type, 2019 & 2026
FIG. 26 Global Cardiac Marker Testing Market for C-reactive protein, Revenue (USD Million) 2016 - 2026
FIG. 27 Global Cardiac Marker Testing Market for Troponin I and T, Revenue (USD Million) 2016 - 2026
FIG. 28 Global Cardiac Marker Testing Market for Brain natriuretic peptide or NT-proBNP, Revenue (USD Million) 2016 - 2026
FIG. 29 Global Cardiac Marker Testing Market for CK-MB, Revenue (USD Million) 2016 - 2026
FIG. 30 Global Cardiac Marker Testing Market for Others, Revenue (USD Million) 2016 - 2026
FIG. 31 Global Cardiac Marker Testing Market Revenue Share, by Region, 2019 & 2026
FIG. 32 North AmericaCardiac Marker Testing Market Revenue, 2016 - 2026 (USD Million)
FIG. 33 EuropeCardiac Marker Testing Market Revenue, 2016 - 2026 (USD Million)
FIG. 34 Asia PacificCardiac Marker Testing Market Revenue, 2016 - 2026 (USD Million)
FIG. 35 Latin AmericaCardiac Marker Testing Market Revenue, 2016 - 2026 (USD Million)
FIG. 36 The Middle-East and AfricaCardiac Marker Testing Market Revenue, 2016 - 2026 (USD Million)
FIG. 37 Siemens AGBusiness Segment Revenue Share, 2018 (%)
FIG. 38 Siemens AGGeographical Segment Revenue Share, 2018 (%)


Table Of Tables

List of Tables

TABLE 1 Global Cardiac Marker TestingMarket: Snapshot
TABLE 2 Drivers of the Cardiac Marker TestingMarket: Impact Analysis
TABLE 3 Restraints for the Cardiac Marker TestingMarket: Impact Analysis
TABLE 4 GlobalCardiac Marker TestingMarket Revenue, by Region, 2016 – 2026 (USD Million)
TABLE 5 North AmericaCardiac Marker TestingMarket Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 6 North AmericaCardiac Marker Testing Market Revenue, by Diseases, 2016 – 2026 (USD Million)
TABLE 7 North AmericaCardiac Marker Testing Market Revenue, by Testing, 2016 – 2026 (USD Million)
TABLE 8 North AmericaCardiac Marker Testing Market Revenue, by Product Type, 2016 – 2026 (USD Million)
TABLE 9 North AmericaCardiac Marker Testing Market Revenue, by Type, 2016 – 2026 (USD Million)
TABLE 10 EuropeCardiac Marker TestingMarket Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 11 EuropeCardiac Marker Testing Market Revenue, by Diseases, 2016 – 2026 (USD Million)
TABLE 12 EuropeCardiac Marker Testing Market Revenue, by Testing, 2016 – 2026 (USD Million)
TABLE 13 EuropeCardiac Marker Testing Market Revenue, by Product Type, 2016 – 2026 (USD Million)
TABLE 14 EuropeCardiac Marker Testing Market Revenue, by Type, 2016 – 2026 (USD Million)
TABLE 15 Asia PacificCardiac Marker TestingMarket Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 16 Asia PacificCardiac Marker Testing Market Revenue, by Diseases, 2016 – 2026 (USD Million)
TABLE 17 Asia PacificCardiac Marker Testing Market Revenue, by Testing, 2016 – 2026 (USD Million)
TABLE 18 Asia PacificCardiac Marker Testing Market Revenue, by Product Type, 2016 – 2026 (USD Million)
TABLE 19 Asia PacificCardiac Marker Testing Market Revenue, by Type, 2016 – 2026 (USD Million)
TABLE 20 Latin AmericaCardiac Marker TestingMarket Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 21 Latin AmericaCardiac Marker Testing Market Revenue, by Diseases, 2016 – 2026 (USD Million)
TABLE 22 Latin AmericaCardiac Marker Testing Market Revenue, by Testing, 2016 – 2026 (USD Million)
TABLE 23 Latin AmericaCardiac Marker Testing Market Revenue, by Product Type, 2016 – 2026 (USD Million)
TABLE 24 Latin AmericaCardiac Marker Testing Market Revenue, by Type, 2016 – 2026 (USD Million)
TABLE 25 The Middle-East and AfricaCardiac Marker TestingMarket Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 26 The Middle-East and AfricaCardiac Marker Testing Market Revenue, by Diseases, 2016 – 2026 (USD Million)
TABLE 27 The Middle-East and AfricaCardiac Marker Testing Market Revenue, by Testing, 2016 – 2026 (USD Million)
TABLE 28 The Middle-East and AfricaCardiac Marker Testing Market Revenue, by Product Type, 2016 – 2026 (USD Million)
TABLE 29 The Middle-East and AfricaCardiac Marker Testing Market Revenue, by Type, 2016 – 2026 (USD Million)

Methodology

FrequentlyAsked Questions

Cardiac marker testing measures specific proteins in blood. It helps diagnose heart attacks and cardiac conditions.
The global Cardiac Marker Testing market is expected to be driven by the rising cardiovascular disease prevalence and demand for early diagnosis. Advancements in point-of-care testing support market expansion.
According to study, the global Cardiac Marker Testing market size was worth around USD 4.30 Billion in 2023 and is predicted to grow to around USD 9.29 Billion By 2032.
The global Cardiac Marker Testing market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 9.05% during the forecast period from 2024-2032.
The global Cardiac Marker Testing industry is projected to be challenged by Challenges include high test costs, need for rapid accuracy, and reimbursement variability.
The Opportunities include rising cardiovascular disease prevalence, emergency diagnostics demand, point-of-care testing growth, and hospital adoption will offer significant growth opportunities in the Cardiac Marker Testing market.
High-sensitivity and rapid diagnostic assays; point-of-care testing expansion; integration with digital health and emergency care workflows are the emerging trends and innovations impacting the Cardiac Marker Testing market.
The global Cardiac Marker Testing market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global Cardiac Marker Testing market are; Siemens AG, Abbott Laboratories, Danaher Corporation, bioMérieux SA, Alere, Inc., Roche Diagnostics Ltd., Ortho Clinical Diagnostics, LSI Medience Corporation, Randox laboratories Ltd, Guangzhou Wondfo Biotech Co., Ltd., Bio-Rad Laboratories,Inc., Helomics Corporation, Becton, Dickinson and Company, Avantra Biosciences, and Enzo Biochem. and others.
The report explores crucial aspects of the Cardiac Marker Testing market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
  • zion payment modes

List of Contents

Market Industry PerspectiveOverviewSegmentationReport ScopeCompetitive PlayersRegional Segment Analysis

HappyClients